Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
World-Class Speaking Faculty Leads Discussion on Changing the Direction of Prevention and Treatment at the 10th Annual Alzheimer's Disease Conference
February 2nd, 2008
ALM's Strategic Research Institute announced its 10th Annual Alzheimer's Disease Conference. This must-attend event will bring together leaders from industry and academia to discuss novel advances in Alzheimer's Disease (AD) drug discovery and therapeutics. "I am very excited about this program that covers many aspects of Alzheimer's Disease, bridging cutting-edge research to developments in the clinic," said Bruce Morimoto, Vice President of Drug Development at Allon Therapeutics and Conference Co-Chairman. "This conference is the best in the industry because presentations will include the latest in our understanding of the mechanism of AD as well as a discussion of...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2008-02-02)
|
